Invention Grant
US08541465B2 Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
有权
含硫辛酸和/或二氢硫辛酸的多西他赛制剂
- Patent Title: Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
- Patent Title (中): 含硫辛酸和/或二氢硫辛酸的多西他赛制剂
-
Application No.: US12589145Application Date: 2009-10-19
-
Publication No.: US08541465B2Publication Date: 2013-09-24
- Inventor: Nageswara R. Palepu
- Applicant: Nageswara R. Palepu
- Applicant Address: US MA Amherst
- Assignee: SciDose, LLC
- Current Assignee: SciDose, LLC
- Current Assignee Address: US MA Amherst
- Agency: Frommer Lawrence & Haug LLP
- Agent Sandra Kuzmich; Russell A. Garman
- Main IPC: A61K31/337
- IPC: A61K31/337 ; A61K31/385

Abstract:
Formulations comprising docetaxel or a salt thereof in combination with α-lipoic acid and/or dihydrolipoic acid and/or salts thereof in narrow concentration ranges have improved stability as concentrate liquid formulations and permit longer times between dilution from higher concentrations through completion of infusions prepared therefrom allowing for lesser waste and more efficient use of personnel in infusion preparation.
Public/Granted literature
- US20110092580A1 Docetaxel formulations with lipoic acid and/or dihydrolipoic acid Public/Granted day:2011-04-21
Information query